Publicaciones en las que colabora con Eduardo Collantes Estévez (20)

2019

  1. Recommendations for the prescription of physical exercise for patients with spondyloarthritis

    Reumatologia Clinica, Vol. 15, Núm. 2, pp. 77-83

2018

  1. Development of a checklist for patients with axial spondyloarthritis and psoriatic arthritis in daily practice: ONLY TOOLS project

    Reumatologia Clinica, Vol. 14, Núm. 3, pp. 155-159

2017

  1. Identification and management of comorbidity in psoriatic arthritis: evidence- and expert-based recommendations from a multidisciplinary panel from Spain

    Rheumatology International, Vol. 37, Núm. 8, pp. 1239-1248

2016

  1. Evaluation of the impact of nursing clinics in the rheumatology services

    Rheumatology International, Vol. 36, Núm. 9, pp. 1309-1317

2014

  1. Development and validation of a new instrument to measure health-related quality of life in patients with psoriatic arthritis: The VITACORA-19

    Journal of Rheumatology, Vol. 41, Núm. 10, pp. 2008-2017

2013

  1. Comparación de 2 estrategias de derivación en el diagnóstico de la espondiloartritis axial en España. Estudio RADAR

    Reumatologia Clinica, Vol. 9, Núm. 6, pp. 348-352

  2. Diferente expresión clínica de los pacientes con espondilitis anquilosante según el sexo en función del tiempo de evolución. Datos de REGISPONSER

    Reumatologia Clinica, Vol. 9, Núm. 4, pp. 221-225

2011

  1. Fine mapping of a major histocompatibility complex in ankylosing spondylitis: Association of the HLA-DPA1 and HLA-DPB1 regions

    Arthritis and Rheumatism, Vol. 63, Núm. 11, pp. 3305-3312

  2. High-dose etanercept in ankylosing spondylitis: Results of a 12-week randomized, double blind, controlled multicentre study (LOADET study)

    Rheumatology, Vol. 50, Núm. 10, pp. 1828-1837

  3. Prevalence of vertebral fractures by semiautomated morphometry in patients with ankylosing spondylitis

    Journal of Rheumatology, Vol. 38, Núm. 5, pp. 893-897

2010

  1. Fibromyalgia in patients with ankylosing spondylitis: Prevalence and utility of the measures of activity, function and radiological damage

    Clinical and Experimental Rheumatology, Vol. 28, Núm. 6 SUPPL. 63

2009

  1. First signs and symptoms of spondyloarthritis-data from an inception cohort with a disease course of two years or less (REGISPONSER-Early)

    Rheumatology, Vol. 48, Núm. 4, pp. 404-409

  2. Relationship between spinal mobility and disease activity, function, quality of life and radiology. A cross-sectional Spanish registry of spondyloarthropathies (REGISPONSER)

    Clinical and Experimental Rheumatology, Vol. 27, Núm. 3, pp. 439-445

2008

  1. Adalimumab effectively reduces the signs and symptoms of active ankylosing spondylitis in patients with total spinal ankylosis

    Annals of the Rheumatic Diseases, Vol. 67, Núm. 9, pp. 1218-1221

  2. Registro Nacional de Pacientes con Espondiloartritis (REGISPONSER). Análisis descriptivo de los 2.367 pacientes españoles incluidos

    Reumatologia Clinica Suplementos, Vol. 4, Núm. SUPPL. 4, pp. 48-55

2007

  1. Disease pattern of spondyloarthropathies in Spain: Description of the first national registry (REGISPONSER) - Extended report

    Rheumatology, Vol. 46, Núm. 8, pp. 1309-1315

2005

  1. Effectiveness of reducing infliximab dose interval in non-responder patients with refractory spondyloarthropathies. An open extension of a multicentre study

    Rheumatology, Vol. 44, Núm. 12, pp. 1555-1558

2003

  1. Infliximab in refractory spondyloarthropathies: A multicentre 38 week open study

    Annals of the Rheumatic Diseases, Vol. 62, Núm. 12, pp. 1239-1240

2001

  1. Eficacia del infliximab en espondiloartropatías refractarias. Resultados de la experiencia europea

    Revista Espanola de Reumatologia, Vol. 28, Núm. 9, pp. 400-402

  2. Valoración de la actividad, respuesta al tratamiento y criterios de refractariedad en espondiloartropatías

    Revista Espanola de Reumatologia, Vol. 28, Núm. 9, pp. 387-394